Digestive & Intestinal Remedies (Pharmacies) - Benelux

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$212.60m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.81%, resulting in a market volume of US$221.40m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$7.08 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in Benelux is experiencing steady growth due to customer preferences for natural and organic remedies, as well as an increase in digestive health issues. Customer preferences in the Benelux region are shifting towards natural and organic remedies for digestive and intestinal issues. Consumers are becoming more health-conscious and are seeking products that are free from artificial ingredients and chemicals. This trend is driving the demand for natural remedies such as herbal teas, probiotics, and dietary supplements that promote digestive health. Additionally, consumers are looking for products that are easy to use and convenient, such as chewable tablets or liquid formulations. The market is also being driven by an increase in digestive health issues in the Benelux region. Factors such as stress, poor diet, and sedentary lifestyles are contributing to a rise in digestive disorders such as indigestion, bloating, and irritable bowel syndrome. As a result, consumers are seeking remedies to alleviate these symptoms and improve their overall digestive health. This has led to an increased demand for products that target specific digestive issues, such as antacids, laxatives, and anti-diarrheal medications. In addition to customer preferences and increasing digestive health issues, there are also local special circumstances that are influencing the development of the Digestive & Intestinal Remedies market in Benelux. The Benelux region is known for its high-quality healthcare system and advanced pharmaceutical industry. This has resulted in a wide range of digestive and intestinal remedies being available in pharmacies, including both over-the-counter and prescription medications. The accessibility and availability of these products in pharmacies make them easily accessible to consumers, further driving the market growth. Furthermore, the Benelux region has a strong culture of self-care and self-medication. Consumers in this region are proactive in managing their health and often prefer to treat minor health issues themselves before seeking medical advice. This has led to a high demand for over-the-counter remedies for digestive and intestinal issues, as consumers seek quick and convenient solutions to their symptoms. Underlying macroeconomic factors also play a role in the development of the Digestive & Intestinal Remedies market in Benelux. The region has a stable economy and a high standard of living, which allows consumers to afford healthcare products and remedies. Additionally, the aging population in the Benelux region is contributing to the growth of the market, as older individuals are more prone to digestive health issues and are more likely to seek remedies to manage their symptoms. In conclusion, the Digestive & Intestinal Remedies market in Benelux is growing due to customer preferences for natural and organic remedies, an increase in digestive health issues, local special circumstances such as the availability of a wide range of products in pharmacies, and underlying macroeconomic factors such as a stable economy and an aging population.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.